Abruptio Placentae: Clinical Trials

22 trials for Abruptio Placentae, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 unknown, 3 recruiting, 2 terminated. 5 Not applicable, 4 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Unknown 1, Withdrawn 1
Phase 34Completed 2, Recruiting 1, Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Abruptio Placentae: new trials by email Literature Review of Abruptio Placentae trials Research Report on Abruptio Placentae

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Pre-eclampsia, Oocyte Donation
RecruitingCopenhagen University Hospital, Hvidovre4622024-10-212026-04-13
Effect of Placenta Delivery Method on Pain, Bleeding and Comfort
Uteratonic administration, cord clamping, delivery of the placenta - Placenta Abruptio
Not applicableUnknownTarsus University1402024-05-062024-05-14
Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns
Infant, Premature - Preterm Birth, Low Birth Weight
CompletedHOSPITAL GINECO OBSTETRICO ISIDRO AYORA260002023-11-122024-10-22
BH4 Blood Levels Variations in Pre Eclamptic Women
BH4 blood level - Pre Eclampsia, Eclampsia, Antepartum
CompletedUniversity Tunis El Manar3002023-03-152023-12-07
Tranexamic Acid as an Intervention in Abruptio Placenta
Tranexamic acid injection, Dextrose 5% in water - Vaginal Bleeding, Prolonged Pregnancy
Not applicableCompletedHawler Medical University1162023-01-102025-11-19
Enhancing Prediction of Adverse Pregnancy Outcomes in Africa Through Partnerships and Innovation
Fetal Growth Restriction (FGR), Preterm Birth
RecruitingMakerere University40002022-07-252026-09-28
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
Aspirin 150 mg, Placebo - Chronic Hypertension Complicating Pregnancy, Pre-Eclampsia
Phase 3RecruitingCentre Hospitalier Intercommunal Creteil5002021-02-152026-06-12
Spanish Registry of Pregnant Women With COVID-19
Covid19, Pregnancy Complications
UnknownPuerta de Hierro University Hospital30002020-03-012020-09-22
Study on Retroplacental Hematomas in Finistère
Placental Abruption, Placenta Diseases
CompletedUniversity Hospital, Brest1342019-09-232020-09-11
Plasma Concentration of Biological Markers in Placental Abruption
There is no other intervention, only clinical treatment. - Abruptio Placentae
TerminatedUniversity of Arkansas12019-01-312024-09-03
The Relationship Between Isolated Head Trauma During Pregnancy and Preterm Birth
Superficial Injuries Involving Head With Neck
CompletedSanliurfa Education and Research Hospital902018-01-012024-11-12
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
sampling of the serum marker sFlt1 and PlGF - Pre-Eclampsia, HELLP Syndrome
CompletedCentre Hospitalier Metropole Savoie2332017-01-102022-06-14
Normotensive and Hypertensive Placental Abruptions
clinical assesment - Abruptio Placentae; Affecting Fetus or Newborn
CompletedHatice Akkaya1152016-01-012020-06-29
Low Dose Aspirin for the Prevention of Preeclampsia
Aspirin, Placebo - Preeclampsia
Phase 3UnknownSaint Thomas Hospital, Panama4762013-07-012013-07-01
Progesterone for First Trimester Vaginal Bleeding
dihydroxyprogesterone caproate, Placebo - Threatened Abortion, Pre-Eclampsia
Not applicableWithdrawnSoroka University Medical Center2012-01-012016-10-26
The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta
Pregnancy Related, Trauma
TerminatedWinthrop University Hospital32009-10-012018-05-07
Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
enoxaparin - Fetal Demise, Fetal Growth Restriction
Not applicableCompletedHaEmek Medical Center, Israel1442009-07-012016-02-23
Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia
Lovenox® (enoxaparin), Aspegic ® (Aspirin) - Preeclampsia
Phase 3CompletedAssistance Publique - Hôpitaux de Paris2572009-06-012016-01-20
Magnesium Sulfate vs Placebo for Placental Abruption
Magnesium Sulfate, Normal Saline - Abruptio Placentae
Not applicableCompletedStanford University302004-03-012018-01-02
Impact of the NO-donor Pentaerythrithyltetrantrate on Perinatal Outcome in High-risk Pregnancies
PETN, Placebo control - High Risk Pregnancy
Phase 1 / Phase 2CompletedUniversity of Jena1112002-04-012011-05-27

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Pre-Eclampsia (12)  ·  Fetal Growth Retardation (10)  ·  Premature Birth (6)  ·  Perinatal Death (5)  ·  Pregnancy Complications (4)  ·  Fetal Membranes, Premature Rupture (3)  ·  Stillbirth (3)  ·  Diabetes, Gestational (2)  ·  Eclampsia (2)  ·  Fetal Death (2)  ·  HELLP Syndrome (2)  ·  Hypertension, Pregnancy-Induced (2)  ·  Uterine Hemorrhage (2)  ·  Abortion, Threatened (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (22)  ·  Obstetric Labor Complications (22)  ·  Urogenital Diseases (22)  ·  Placenta Diseases (21)  ·  Pregnancy Complications (18)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Pathologic Processes (14)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (11)  ·  Fetal Diseases (10)  ·  Growth Disorders (10)  ·  Hypertension, Pregnancy-Induced (10)  ·  Death (9)  ·  Obstetric Labor, Premature (6)  ·  Cardiovascular Diseases (5)  ·  Vascular Diseases (5)

Interventions

Aspirin (3)  ·  Enoxaparin (2)  ·  Magnesium Sulfate (2)  ·  Glucose (1)  ·  Saline Solution (1)  ·  Tranexamic Acid (1)  ·  Umbilical Cord Clamping (1)  ·  Water (1)  ·  acetylsalicylic acid lysinate (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Intercommunal Creteil (1)  ·  Centre Hospitalier Metropole Savoie (1)  ·  Copenhagen University Hospital, Hvidovre (1)  ·  HOSPITAL GINECO OBSTETRICO ISIDRO AYORA (1)  ·  HaEmek Medical Center, Israel (1)  ·  Hatice Akkaya (1)  ·  Hawler Medical University (1)  ·  Makerere University (1)  ·  Puerta de Hierro University Hospital (1)  ·  Saint Thomas Hospital, Panama (1)  ·  Sanliurfa Education and Research Hospital (1)  ·  Soroka University Medical Center (1)  ·  Stanford University (1)  ·  Tarsus University (1)

Countries

France (4)  ·  United States (4)  ·  Israel (3)  ·  Turkey (Türkiye) (2)  ·  Denmark (1)  ·  Ecuador (1)  ·  Germany (1)  ·  Iraq (1)  ·  Panama (1)  ·  Spain (1)  ·  Tunisia (1)  ·  Uganda (1)

Top investigators

Alev Esercan, Assoc. Prof. (1)  ·  Ameth Hawkins, MD (1)  ·  Ana Moreno, MD (1)  ·  Annettee Olivia Nakimuli, MBChB, MMED, MBA, PhD (1)  ·  Bassam Haddad (1)  ·  Dwight Rouse, MD (1)  ·  Eli Rimon, MD (1)  ·  Hatice Akkaya, Ass Prof (1)  ·  Hayen Magherbi, pr (1)  ·  Menachem Miodovnik (1)  ·  Nadir Shawrawi, MD (1)  ·  Oscar M Martinez Perez, Epidemiologist (1)  ·  Osvaldo Reyes, MD (1)  ·  Raed Salim, MD (1)

Results publications

PMID 18753646, PMID 19622997, PMID 20027029, PMID 26254839, PMID 26871905, PMID 27440463, PMID 27741174, PMID 29215518, PMID 31143877, PMID 31764746, PMID 32511673, PMID 33779986, PMID 33972083

NIH funding

2018 (1), U10HD021410 (1), U10HD021414 (1), U10HD027860 (1), U10HD027861 (1), U10HD027869 (1), U10HD027905 (1), U10HD027915 (1), U10HD027917 (1), U10HD034116 (1), U10HD034122 (1), U10HD034136 (1), U10HD034208 (1), U10HD034210 (1), U10HD036801 (1)